Dambkowski Carl sold APGE
January 7, 2026 · Form 4 insider transaction
Dambkowski Carl sold 100 shares of Apogee Therapeutics, Inc. at $80.06 per share, a transaction worth $8.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$80.06
Total value
$8.0K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after212,523
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 22, 2025.